Lantheus Announces Payment to Contingent Value Rights (CVR) Holders of $99.7 million or $1.15 per CVR
23 Maio 2023 - 9:30AM
Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company
committed to improving patient outcomes through diagnostics,
radiotherapeutics and artificial intelligence solutions that enable
clinicians to Find, Fight and Follow disease, today announced that
it has instructed the rights agent to distribute $99.7 million to
the holders of Contingent Value Rights (CVRs), which were issued in
conjunction with Lantheus’ acquisition of Progenics
Pharmaceuticals, Inc. on June 19, 2020.
Each CVR entitled its holder to receive a pro rata share of
aggregate cash payments equal to 40% of U.S. net sales generated by
PYLARIFY in 2022 and 2023 in excess of $100.0 million and $150.0
million, respectively, subject to a maximum amount allowed to be
paid. As a result of the net sales generated by PYLARIFY in 2022,
the maximum aggregate cash payment of $99.7 million is being
distributed to the holders. This is the first and final payment
related to the CVRs and is in full satisfaction of Lantheus’
payment obligations related to the CVRs.
If your CVRs are held with your broker, please contact your
broker for information specific to your holdings. If your CVRs are
held at the rights agent, Computershare Trust Company, N.A., please
contact Computershare for information specific to your holdings.
Holders of CVRs should consult their tax advisor as to the tax
treatment of the CVRs.
About Lantheus With more than 65 years of
experience in delivering life-changing science, Lantheus is
committed to improving patient outcomes through diagnostics,
radiotherapeutics and artificial intelligence solutions that enable
clinicians to Find, Fight and Follow disease. Lantheus is
headquartered in Massachusetts and has offices in New Jersey,
Canada and Sweden. For more information, visit
www.lantheus.com.
Contacts: Mark Kinarney Vice President,
Investor Relations 978-671-8842 ir@lantheus.com
Melissa Downs Senior Director, Corporate Communications
646-975-2533 media@lantheus.com
Lantheus (NASDAQ:LNTH)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Lantheus (NASDAQ:LNTH)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024